203 related articles for article (PubMed ID: 34715591)
21. Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Matsumoto Y; Kanamori A; Nakamura M; Takahashi T; Nakashima I; Negi A
Exp Eye Res; 2014 Feb; 119():61-9. PubMed ID: 24374258
[TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis optica pathogenesis and aquaporin 4.
Graber DJ; Levy M; Kerr D; Wade WF
J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
[TBL] [Abstract][Full Text] [Related]
24. Role of AQP4 Antibody Serostatus and its Prediction of Visual Outcome in Neuromyelitis Optica: A Systematic Review and Meta-Analysis.
Lin N; Liu Q; Wang X; Ma J; Li Y
Protein Pept Lett; 2017; 24(3):245-252. PubMed ID: 28071581
[TBL] [Abstract][Full Text] [Related]
25. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
Ringelstein M; Harmel J; Distelmaier F; Ingwersen J; Menge T; Hellwig K; Kieseier B; Mayatepek E; Hartung HP; Kuempfel T; Aktas O
Mult Scler; 2013 Oct; 19(11):1544-7. PubMed ID: 23886825
[TBL] [Abstract][Full Text] [Related]
26. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
27. Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica.
Rosito S; Nicchia GP; Palazzo C; Lia A; Buccoliero C; Pisani F; Svelto M; Trojano M; Frigeri A
J Cell Mol Med; 2018 Feb; 22(2):1236-1246. PubMed ID: 29055082
[TBL] [Abstract][Full Text] [Related]
28. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M
J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662
[TBL] [Abstract][Full Text] [Related]
29. Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
Sun M; Wang J; Zhou Y; Wang Z; Jiang Y; Li M
Neuroimmunomodulation; 2016; 23(2):98-108. PubMed ID: 27064690
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Ishii N; Itoyama Y
Tohoku J Exp Med; 2006 Dec; 210(4):307-13. PubMed ID: 17146196
[TBL] [Abstract][Full Text] [Related]
31. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
32. Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms.
Crane JM; Rossi A; Gupta T; Bennett JL; Verkman AS
J Neuroimmunol; 2011 Jul; 236(1-2):93-8. PubMed ID: 21621278
[TBL] [Abstract][Full Text] [Related]
33. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
Kalluri SR; Illes Z; Srivastava R; Cree B; Menge T; Bennett JL; Berthele A; Hemmer B
Arch Neurol; 2010 Oct; 67(10):1201-8. PubMed ID: 20937947
[TBL] [Abstract][Full Text] [Related]
34. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
35. Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies.
Pisani F; Mola MG; Simone L; Rosito S; Alberga D; Mangiatordi GF; Lattanzi G; Nicolotti O; Frigeri A; Svelto M; Nicchia GP
J Biol Chem; 2014 Oct; 289(44):30578-30589. PubMed ID: 25239624
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
37. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
38. Model of aquaporin-4 supramolecular assembly in orthogonal arrays based on heterotetrameric association of M1-M23 isoforms.
Jin BJ; Rossi A; Verkman AS
Biophys J; 2011 Jun; 100(12):2936-45. PubMed ID: 21689527
[TBL] [Abstract][Full Text] [Related]
39. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
[TBL] [Abstract][Full Text] [Related]
40. Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.
Pisani F; Mastrototaro M; Rossi A; Nicchia GP; Tortorella C; Ruggieri M; Trojano M; Frigeri A; Svelto M
J Biol Chem; 2011 Mar; 286(11):9216-24. PubMed ID: 21212277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
